Rank | Gene Set | Z-score |
---|---|---|
1 | cellular response to interleukin-15 (GO:0071350) | 9.71264061 |
2 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 9.56886235 |
3 | regulation of natural killer cell mediated immunity (GO:0002715) | 9.56886235 |
4 | response to interleukin-15 (GO:0070672) | 8.41195996 |
5 | activated T cell proliferation (GO:0050798) | 8.03284317 |
6 | * cytolysis (GO:0019835) | 7.83558394 |
7 | negative regulation of cell killing (GO:0031342) | 6.82619162 |
8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.82619162 |
9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.55134792 |
10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.41868541 |
11 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 6.33051241 |
12 | * cellular defense response (GO:0006968) | 6.32101814 |
13 | natural killer cell activation (GO:0030101) | 6.30958319 |
14 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.30318872 |
15 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.30318872 |
16 | negative thymic T cell selection (GO:0045060) | 6.28013812 |
17 | negative T cell selection (GO:0043383) | 6.25378322 |
18 | positive thymic T cell selection (GO:0045059) | 5.93248494 |
19 | regulation of cell killing (GO:0031341) | 5.66916995 |
20 | positive regulation of isotype switching (GO:0045830) | 5.58798327 |
21 | T cell migration (GO:0072678) | 5.34827753 |
22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.26960119 |
23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26960119 |
24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.20628921 |
25 | thymic T cell selection (GO:0045061) | 5.15866827 |
26 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 5.08269481 |
27 | positive T cell selection (GO:0043368) | 5.00512521 |
28 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.96502028 |
29 | cytidine deamination (GO:0009972) | 4.92425475 |
30 | cytidine metabolic process (GO:0046087) | 4.92425475 |
31 | cytidine catabolic process (GO:0006216) | 4.92425475 |
32 | positive regulation of DNA recombination (GO:0045911) | 4.75190232 |
33 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.73598797 |
34 | positive regulation of B cell mediated immunity (GO:0002714) | 4.73598797 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.68773266 |
36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.62691283 |
37 | positive regulation of cell killing (GO:0031343) | 4.54890545 |
38 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.53012493 |
39 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.43727362 |
40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.36289765 |
41 | negative regulation of T cell mediated immunity (GO:0002710) | 4.25852743 |
42 | T cell selection (GO:0045058) | 4.24646584 |
43 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.13682833 |
44 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12293661 |
45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.07453536 |
46 | regulation of lymphocyte mediated immunity (GO:0002706) | 4.05655543 |
47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.05624214 |
48 | neutrophil activation involved in immune response (GO:0002283) | 4.01651907 |
49 | regulation of regulatory T cell differentiation (GO:0045589) | 4.00317981 |
50 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.00194501 |
51 | leukocyte aggregation (GO:0070486) | 3.97422657 |
52 | substrate-dependent cell migration (GO:0006929) | 3.97402439 |
53 | regulation of T cell tolerance induction (GO:0002664) | 3.97343837 |
54 | heterotypic cell-cell adhesion (GO:0034113) | 3.95198442 |
55 | positive regulation of B cell differentiation (GO:0045579) | 3.94297710 |
56 | regulation of isotype switching (GO:0045191) | 3.91582028 |
57 | regulation of hypersensitivity (GO:0002883) | 3.88186994 |
58 | lymphocyte migration (GO:0072676) | 3.87282177 |
59 | neutrophil activation (GO:0042119) | 3.85380633 |
60 | leukocyte cell-cell adhesion (GO:0007159) | 3.84769331 |
61 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.84191500 |
62 | regulation of response to interferon-gamma (GO:0060330) | 3.82274414 |
63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.79878903 |
64 | sequestering of actin monomers (GO:0042989) | 3.79197321 |
65 | T cell costimulation (GO:0031295) | 3.77975262 |
66 | regulation of tolerance induction (GO:0002643) | 3.77076231 |
67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.76549137 |
68 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.75175821 |
69 | granulocyte activation (GO:0036230) | 3.73650972 |
70 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.71488311 |
71 | DNA deamination (GO:0045006) | 3.70321436 |
72 | T cell receptor signaling pathway (GO:0050852) | 3.70317733 |
73 | T cell differentiation involved in immune response (GO:0002292) | 3.69942277 |
74 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.69942277 |
75 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.69942277 |
76 | lymphocyte costimulation (GO:0031294) | 3.69046725 |
77 | positive regulation of humoral immune response (GO:0002922) | 3.68697354 |
78 | T cell proliferation (GO:0042098) | 3.68271505 |
79 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66131450 |
80 | detection of bacterium (GO:0016045) | 3.64932711 |
81 | macrophage activation involved in immune response (GO:0002281) | 3.64773962 |
82 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.62529101 |
83 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.62037769 |
84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61689726 |
85 | modulation by symbiont of host defense response (GO:0052031) | 3.61689726 |
86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61689726 |
87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61689726 |
88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61689726 |
89 | modulation by symbiont of host immune response (GO:0052553) | 3.61689726 |
90 | cellular response to type I interferon (GO:0071357) | 3.61095419 |
91 | type I interferon signaling pathway (GO:0060337) | 3.61095419 |
92 | detection of other organism (GO:0098543) | 3.59429680 |
93 | response to type I interferon (GO:0034340) | 3.58048021 |
94 | alpha-beta T cell activation (GO:0046631) | 3.56993910 |
95 | dendritic cell chemotaxis (GO:0002407) | 3.54593402 |
96 | negative regulation of interleukin-12 production (GO:0032695) | 3.54488255 |
97 | cellular extravasation (GO:0045123) | 3.54362449 |
98 | regulation of activation of Janus kinase activity (GO:0010533) | 3.49924504 |
99 | regulation of B cell mediated immunity (GO:0002712) | 3.49775102 |
100 | B cell receptor signaling pathway (GO:0050853) | 3.48703958 |
101 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.48295245 |
102 | hypotonic response (GO:0006971) | 3.46421311 |
103 | alpha-beta T cell differentiation (GO:0046632) | 3.45993301 |
104 | positive regulation of immunoglobulin production (GO:0002639) | 3.44735086 |
105 | skin morphogenesis (GO:0043589) | 3.42629101 |
106 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.40856028 |
107 | T cell activation involved in immune response (GO:0002286) | 3.39620044 |
108 | response to protozoan (GO:0001562) | 3.37605861 |
109 | immunoglobulin mediated immune response (GO:0016064) | 3.35349350 |
110 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.33991940 |
111 | respiratory burst (GO:0045730) | 3.32213799 |
112 | positive regulation of interferon-gamma production (GO:0032729) | 3.32138409 |
113 | myeloid cell activation involved in immune response (GO:0002275) | 3.31267094 |
114 | regulation of leukocyte mediated immunity (GO:0002703) | 3.28609507 |
115 | dendritic cell migration (GO:0036336) | 3.27685791 |
116 | negative regulation of phagocytosis (GO:0050765) | 3.25521347 |
117 | lymphocyte chemotaxis (GO:0048247) | 3.24832408 |
118 | positive regulation of tolerance induction (GO:0002645) | 3.23887645 |
119 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19866430 |
120 | citrulline biosynthetic process (GO:0019240) | 3.19371582 |
121 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.18310598 |
122 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.17008868 |
123 | leukocyte degranulation (GO:0043299) | 3.14783016 |
124 | regulation of B cell differentiation (GO:0045577) | 3.13877765 |
125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.13580137 |
126 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.12141484 |
127 | T cell differentiation (GO:0030217) | 3.11083503 |
128 | negative regulation of viral genome replication (GO:0045071) | 3.10586906 |
129 | regulation of response to tumor cell (GO:0002834) | 3.09869394 |
130 | positive regulation of response to tumor cell (GO:0002836) | 3.09869394 |
131 | positive regulation of immune response to tumor cell (GO:0002839) | 3.09869394 |
132 | regulation of immune response to tumor cell (GO:0002837) | 3.09869394 |
133 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08649642 |
134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08536131 |
135 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.07695617 |
136 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.07386999 |
137 | negative regulation of innate immune response (GO:0045824) | 3.06142906 |
138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05777952 |
139 | negative regulation of B cell proliferation (GO:0030889) | 3.05161041 |
140 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.03107199 |
141 | negative regulation of T cell apoptotic process (GO:0070233) | 3.03031597 |
142 | mast cell activation (GO:0045576) | 2.93680960 |
143 | negative regulation of oxidoreductase activity (GO:0051354) | 2.91197362 |
144 | T cell activation (GO:0042110) | 2.90906142 |
145 | regulation of alkaline phosphatase activity (GO:0010692) | 2.85804278 |
146 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.84880600 |
147 | interferon-gamma production (GO:0032609) | 13.4731274 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.80558321 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.53430459 |
3 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 5.23245253 |
4 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.65855647 |
5 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.76379304 |
6 | MYB_26560356_Chip-Seq_TH2_Human | 3.65794506 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.65328568 |
8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.58004218 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27428866 |
10 | MYB_26560356_Chip-Seq_TH1_Human | 3.09239284 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04943173 |
12 | MAF_26560356_Chip-Seq_TH1_Human | 3.00908755 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.98050590 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84329752 |
15 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74998340 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71542403 |
17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.71232603 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 2.62935039 |
19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42093586 |
20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32577040 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16736280 |
22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.16117675 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15691817 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14977301 |
25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12886561 |
26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10615576 |
27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08712078 |
28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06770076 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.01015958 |
30 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.99883544 |
31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.95419324 |
32 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92962019 |
33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92394848 |
34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.90913155 |
35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.90191509 |
36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87043881 |
37 | MAF_26560356_Chip-Seq_TH2_Human | 1.83124640 |
38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.82529421 |
39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82261399 |
40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79043365 |
41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77401161 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75030072 |
43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73745947 |
44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.73428274 |
45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66573184 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62575997 |
47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57997936 |
48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.55432143 |
49 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.55151695 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54630148 |
51 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53063454 |
52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41827366 |
53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37400758 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34322930 |
55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29783447 |
56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.29251536 |
57 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26843554 |
58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26836139 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24777519 |
60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20195708 |
61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17553121 |
62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16211722 |
63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15827003 |
64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15300530 |
65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15006404 |
66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14179122 |
67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08949969 |
68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07958536 |
69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05040515 |
70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03174424 |
71 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00819829 |
72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00394037 |
73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00385413 |
74 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.99661930 |
75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98885223 |
76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98587851 |
77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98442404 |
78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97729640 |
79 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96540480 |
80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96206654 |
81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94178114 |
82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93485895 |
83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92222956 |
84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92202318 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91647020 |
86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90050295 |
87 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86228802 |
88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85456826 |
89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84983844 |
90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.82833045 |
91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82826818 |
92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82383108 |
93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82336769 |
94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82336769 |
95 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81645186 |
96 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81435301 |
97 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.81054516 |
98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80378120 |
99 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.79807672 |
100 | GATA1_22025678_ChIP-Seq_K562_Human | 0.78870095 |
101 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.78043312 |
102 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77516959 |
103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77402603 |
104 | SA1_27219007_Chip-Seq_Bcells_Human | 0.76844655 |
105 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.76313111 |
106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76190113 |
107 | P300_27268052_Chip-Seq_Bcells_Human | 0.76072673 |
108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.75779847 |
109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75685704 |
110 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75427918 |
111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73859784 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73190339 |
113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72296282 |
114 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71661916 |
115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.71553365 |
116 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70313499 |
117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67428767 |
118 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.67302448 |
119 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.65914336 |
120 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65435097 |
121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.64541015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0005671_abnormal_response_to | 6.91965494 |
2 | * MP0006082_CNS_inflammation | 4.02642048 |
3 | MP0009785_altered_susceptibility_to | 3.68656636 |
4 | MP0003763_abnormal_thymus_physiology | 3.60350088 |
5 | MP0003950_abnormal_plasma_membrane | 3.33234391 |
6 | * MP0003448_altered_tumor_morphology | 3.20096076 |
7 | * MP0001800_abnormal_humoral_immune | 3.17850821 |
8 | * MP0005025_abnormal_response_to | 3.13395492 |
9 | MP0000858_altered_metastatic_potential | 3.07838264 |
10 | * MP0002420_abnormal_adaptive_immunity | 3.04541168 |
11 | * MP0001819_abnormal_immune_cell | 3.00363351 |
12 | MP0009333_abnormal_splenocyte_physiolog | 2.88248433 |
13 | * MP0002723_abnormal_immune_serum | 2.83285680 |
14 | MP0005387_immune_system_phenotype | 2.82178036 |
15 | MP0001790_abnormal_immune_system | 2.82178036 |
16 | MP0002132_abnormal_respiratory_system | 2.56716279 |
17 | * MP0005000_abnormal_immune_tolerance | 2.56300563 |
18 | MP0000685_abnormal_immune_system | 2.50108427 |
19 | MP0001873_stomach_inflammation | 2.47506825 |
20 | * MP0002452_abnormal_antigen_presenting | 2.47465666 |
21 | * MP0002398_abnormal_bone_marrow | 2.41866544 |
22 | MP0002006_tumorigenesis | 2.30321147 |
23 | * MP0000716_abnormal_immune_system | 2.27406595 |
24 | MP0003300_gastrointestinal_ulcer | 2.24227555 |
25 | MP0010155_abnormal_intestine_physiology | 2.13307263 |
26 | MP0002405_respiratory_system_inflammati | 2.12736124 |
27 | * MP0001835_abnormal_antigen_presentation | 2.04486013 |
28 | MP0002166_altered_tumor_susceptibility | 2.01411454 |
29 | MP0002148_abnormal_hypersensitivity_rea | 2.00962050 |
30 | * MP0002722_abnormal_immune_system | 2.00571690 |
31 | * MP0000703_abnormal_thymus_morphology | 1.97338972 |
32 | MP0002419_abnormal_innate_immunity | 1.95981383 |
33 | MP0005464_abnormal_platelet_physiology | 1.94087556 |
34 | MP0003724_increased_susceptibility_to | 1.89300659 |
35 | * MP0000689_abnormal_spleen_morphology | 1.84515159 |
36 | MP0004947_skin_inflammation | 1.84446292 |
37 | MP0003866_abnormal_defecation | 1.82647794 |
38 | * MP0002429_abnormal_blood_cell | 1.81453824 |
39 | * MP0001845_abnormal_inflammatory_respons | 1.71768215 |
40 | MP0003436_decreased_susceptibility_to | 1.70758552 |
41 | MP0004510_myositis | 1.60509210 |
42 | MP0001851_eye_inflammation | 1.57248419 |
43 | * MP0008469_abnormal_protein_level | 1.43836485 |
44 | MP0003690_abnormal_glial_cell | 1.40756613 |
45 | MP0002933_joint_inflammation | 1.36293544 |
46 | MP0002998_abnormal_bone_remodeling | 1.30050299 |
47 | MP0005166_decreased_susceptibility_to | 1.27966001 |
48 | MP0000343_altered_response_to | 1.26384753 |
49 | MP0002254_reproductive_system_inflammat | 1.25731522 |
50 | MP0002396_abnormal_hematopoietic_system | 1.25461918 |
51 | MP0002277_abnormal_respiratory_mucosa | 1.24649732 |
52 | MP0003172_abnormal_lysosome_physiology | 1.24265761 |
53 | MP0005310_abnormal_salivary_gland | 1.17146437 |
54 | MP0000604_amyloidosis | 1.16118782 |
55 | MP0001533_abnormal_skeleton_physiology | 1.14340961 |
56 | MP0006054_spinal_hemorrhage | 1.10230022 |
57 | * MP0009763_increased_sensitivity_to | 1.09120322 |
58 | MP0003566_abnormal_cell_adhesion | 1.08674625 |
59 | MP0000490_abnormal_crypts_of | 1.07567020 |
60 | MP0003303_peritoneal_inflammation | 1.07303425 |
61 | MP0003183_abnormal_peptide_metabolism | 1.07170080 |
62 | MP0005075_abnormal_melanosome_morpholog | 1.05256402 |
63 | * MP0002019_abnormal_tumor_incidence | 1.04473167 |
64 | MP0010352_gastrointestinal_tract_polyps | 1.01819309 |
65 | MP0004808_abnormal_hematopoietic_stem | 0.94760373 |
66 | MP0000613_abnormal_salivary_gland | 0.92230244 |
67 | MP0001986_abnormal_taste_sensitivity | 0.91091011 |
68 | MP0004883_abnormal_blood_vessel | 0.90430672 |
69 | MP0003045_fibrosis | 0.88867140 |
70 | MP0008260_abnormal_autophagy | 0.86493471 |
71 | MP0003329_amyloid_beta_deposits | 0.84541906 |
72 | MP0005023_abnormal_wound_healing | 0.81508163 |
73 | MP0003075_altered_response_to | 0.80873937 |
74 | MP0000465_gastrointestinal_hemorrhage | 0.79663285 |
75 | MP0000609_abnormal_liver_physiology | 0.78327331 |
76 | MP0008438_abnormal_cutaneous_collagen | 0.78177547 |
77 | MP0004130_abnormal_muscle_cell | 0.77285242 |
78 | MP0003279_aneurysm | 0.75989662 |
79 | MP0003828_pulmonary_edema | 0.74348340 |
80 | MP0005451_abnormal_body_composition | 0.72038571 |
81 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71163331 |
82 | MP0004381_abnormal_hair_follicle | 0.68541283 |
83 | MP0005397_hematopoietic_system_phenotyp | 0.66612128 |
84 | MP0001545_abnormal_hematopoietic_system | 0.66612128 |
85 | MP0000249_abnormal_blood_vessel | 0.65224994 |
86 | MP0003091_abnormal_cell_migration | 0.63447588 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.62915200 |
88 | * MP0000920_abnormal_myelination | 0.62751758 |
89 | MP0001853_heart_inflammation | 0.58908373 |
90 | MP0002163_abnormal_gland_morphology | 0.57946381 |
91 | MP0002136_abnormal_kidney_physiology | 0.54034672 |
92 | MP0003943_abnormal_hepatobiliary_system | 0.53765514 |
93 | * MP0008873_increased_physiological_sensi | 0.53730928 |
94 | * MP0002693_abnormal_pancreas_physiology | 0.53626484 |
95 | MP0001348_abnormal_lacrimal_gland | 0.52489712 |
96 | MP0003795_abnormal_bone_structure | 0.51227103 |
97 | MP0005377_hearing/vestibular/ear_phenot | 0.50970991 |
98 | MP0003878_abnormal_ear_physiology | 0.50970991 |
99 | MP0009384_cardiac_valve_regurgitation | 0.50611418 |
100 | MP0001958_emphysema | 0.48605367 |
101 | MP0002086_abnormal_extraembryonic_tissu | 0.48178173 |
102 | MP0003191_abnormal_cellular_cholesterol | 0.47569705 |
103 | MP0005058_abnormal_lysosome_morphology | 0.47440059 |
104 | MP0003453_abnormal_keratinocyte_physiol | 0.47197826 |
105 | MP0008874_decreased_physiological_sensi | 0.46366786 |
106 | MP0000367_abnormal_coat/_hair | 0.43903946 |
107 | MP0008961_abnormal_basal_metabolism | 0.43234169 |
108 | MP0001663_abnormal_digestive_system | 0.43000643 |
109 | MP0004142_abnormal_muscle_tone | 0.42580231 |
110 | MP0009764_decreased_sensitivity_to | 0.41582789 |
111 | MP0000477_abnormal_intestine_morphology | 0.41231029 |
112 | MP0005164_abnormal_response_to | 0.40980809 |
113 | MP0005381_digestive/alimentary_phenotyp | 0.40895620 |
114 | MP0002009_preneoplasia | 0.40517448 |
115 | MP0009278_abnormal_bone_marrow | 0.39614923 |
116 | MP0003890_abnormal_embryonic-extraembry | 0.39271585 |
117 | MP0001919_abnormal_reproductive_system | 0.38941989 |
118 | * MP0002083_premature_death | 0.37713047 |
119 | MP0005390_skeleton_phenotype | 0.37528679 |
120 | MP0001765_abnormal_ion_homeostasis | 0.37046761 |
121 | MP0001915_intracranial_hemorrhage | 0.36130869 |
122 | MP0002138_abnormal_hepatobiliary_system | 0.35996228 |
123 | * MP0009642_abnormal_blood_homeostasis | 0.35791642 |
124 | MP0000015_abnormal_ear_pigmentation | 0.35461768 |
125 | MP0002168_other_aberrant_phenotype | 0.35289350 |
126 | MP0000470_abnormal_stomach_morphology | 0.32227647 |
127 | MP0005083_abnormal_biliary_tract | 0.31392725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nasal polyposis (HP:0100582) | 6.94672877 |
2 | T lymphocytopenia (HP:0005403) | 6.09318045 |
3 | Joint swelling (HP:0001386) | 5.84992328 |
4 | Abnormality of the nasal mucosa (HP:0000433) | 5.79968456 |
5 | Abnormality of T cell number (HP:0011839) | 5.76692305 |
6 | Myositis (HP:0100614) | 5.62339293 |
7 | Retrobulbar optic neuritis (HP:0100654) | 5.56705819 |
8 | Optic neuritis (HP:0100653) | 5.56705819 |
9 | Recurrent bacterial skin infections (HP:0005406) | 5.09394048 |
10 | Orchitis (HP:0100796) | 5.06133530 |
11 | Increased IgM level (HP:0003496) | 4.59291730 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.09957531 |
13 | Keratoconjunctivitis sicca (HP:0001097) | 4.07560877 |
14 | * Abnormality of macrophages (HP:0004311) | 3.98893521 |
15 | Spontaneous hematomas (HP:0007420) | 3.98700531 |
16 | Autoimmune hemolytic anemia (HP:0001890) | 3.96729321 |
17 | Increased density of long bones (HP:0006392) | 3.88082447 |
18 | Recurrent skin infections (HP:0001581) | 3.79629665 |
19 | Abnormality of T cells (HP:0002843) | 3.71525875 |
20 | Keratoconjunctivitis (HP:0001096) | 3.68193111 |
21 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.66587806 |
22 | Recurrent bronchitis (HP:0002837) | 3.63826419 |
23 | Chronic otitis media (HP:0000389) | 3.50958452 |
24 | * Encephalitis (HP:0002383) | 3.43621057 |
25 | Abnormality of T cell physiology (HP:0011840) | 3.42760609 |
26 | Arterial thrombosis (HP:0004420) | 3.31137476 |
27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27786815 |
28 | Pulmonary embolism (HP:0002204) | 3.26642180 |
29 | Increased IgE level (HP:0003212) | 3.22608311 |
30 | Aortic dissection (HP:0002647) | 3.16307081 |
31 | Inflammation of the large intestine (HP:0002037) | 3.14884437 |
32 | Eczematoid dermatitis (HP:0000976) | 3.12654474 |
33 | IgM deficiency (HP:0002850) | 3.12452538 |
34 | Hypochromic anemia (HP:0001931) | 3.12050209 |
35 | Aortic aneurysm (HP:0004942) | 3.11988312 |
36 | Spondylolisthesis (HP:0003302) | 3.06368672 |
37 | Recurrent abscess formation (HP:0002722) | 3.04918391 |
38 | Gingivitis (HP:0000230) | 3.00860210 |
39 | Gastrointestinal inflammation (HP:0004386) | 3.00375575 |
40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98979950 |
41 | Recurrent viral infections (HP:0004429) | 2.98685446 |
42 | Chronic diarrhea (HP:0002028) | 2.97658113 |
43 | Agammaglobulinemia (HP:0004432) | 2.96718858 |
44 | Pulmonary infiltrates (HP:0002113) | 2.94094093 |
45 | Absent frontal sinuses (HP:0002688) | 2.92462502 |
46 | Recurrent fungal infections (HP:0002841) | 2.91146842 |
47 | Vasculitis (HP:0002633) | 2.89639362 |
48 | Gingival bleeding (HP:0000225) | 2.83911490 |
49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82387172 |
50 | Urticaria (HP:0001025) | 2.81916138 |
51 | Arterial tortuosity (HP:0005116) | 2.80338919 |
52 | * Meningitis (HP:0001287) | 2.79984875 |
53 | Hemoptysis (HP:0002105) | 2.77486163 |
54 | Eosinophilia (HP:0001880) | 2.77129816 |
55 | Pustule (HP:0200039) | 2.73150596 |
56 | Abnormality of binocular vision (HP:0011514) | 2.69559690 |
57 | Diplopia (HP:0000651) | 2.69559690 |
58 | Abnormal platelet volume (HP:0011876) | 2.67438558 |
59 | Purpura (HP:0000979) | 2.62413031 |
60 | Severe combined immunodeficiency (HP:0004430) | 2.60449625 |
61 | Prolonged bleeding time (HP:0003010) | 2.55720473 |
62 | Leukocytosis (HP:0001974) | 2.54738113 |
63 | Combined immunodeficiency (HP:0005387) | 2.54482930 |
64 | Abnormality of eosinophils (HP:0001879) | 2.54394418 |
65 | Anorexia (HP:0002039) | 2.51733833 |
66 | Periodontitis (HP:0000704) | 2.50717428 |
67 | Petechiae (HP:0000967) | 2.49570914 |
68 | Bicuspid aortic valve (HP:0001647) | 2.46572156 |
69 | Vascular tortuosity (HP:0004948) | 2.44227820 |
70 | Epistaxis (HP:0000421) | 2.44099812 |
71 | Acute hepatic failure (HP:0006554) | 2.42837166 |
72 | Abnormality of the fingertips (HP:0001211) | 2.42666257 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.40391275 |
74 | Obstructive lung disease (HP:0006536) | 2.40391275 |
75 | Abnormality of the pleura (HP:0002103) | 2.40125977 |
76 | Chronic sinusitis (HP:0011109) | 2.38736944 |
77 | Episodic fever (HP:0001954) | 2.37848046 |
78 | Osteolytic defects of the hand bones (HP:0009699) | 2.37178362 |
79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37178362 |
80 | Gastrointestinal infarctions (HP:0005244) | 2.33977068 |
81 | Hypochromic microcytic anemia (HP:0004840) | 2.33083285 |
82 | Abnormality of oral frenula (HP:0000190) | 2.30006189 |
83 | Chest pain (HP:0100749) | 2.29828265 |
84 | Ureteral stenosis (HP:0000071) | 2.28812138 |
85 | Granulocytopenia (HP:0001913) | 2.27963456 |
86 | Persistence of primary teeth (HP:0006335) | 2.27279070 |
87 | Panhypogammaglobulinemia (HP:0003139) | 2.27228801 |
88 | Hypoplasia of the thymus (HP:0000778) | 2.27010234 |
89 | Stomatitis (HP:0010280) | 2.26716890 |
90 | Gangrene (HP:0100758) | 2.26047322 |
91 | Arthralgia (HP:0002829) | 2.24209592 |
92 | Impaired platelet aggregation (HP:0003540) | 2.22656539 |
93 | Abnormal platelet function (HP:0011869) | 2.22656539 |
94 | Dilatation of the ascending aorta (HP:0005111) | 2.19474009 |
95 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.17862765 |
96 | Striae distensae (HP:0001065) | 2.17713965 |
97 | Colitis (HP:0002583) | 2.16816704 |
98 | Microcytic anemia (HP:0001935) | 2.16407379 |
99 | Menorrhagia (HP:0000132) | 2.16311487 |
100 | Cellulitis (HP:0100658) | 2.16236369 |
101 | Increased mean platelet volume (HP:0011877) | 2.15797569 |
102 | Mediastinal lymphadenopathy (HP:0100721) | 2.13211462 |
103 | Dysostosis multiplex (HP:0000943) | 2.13147340 |
104 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.09433007 |
105 | Aplastic anemia (HP:0001915) | 2.09373644 |
106 | Autoimmune thrombocytopenia (HP:0001973) | 2.07973143 |
107 | Ureteral obstruction (HP:0006000) | 2.07960978 |
108 | Cerebral aneurysm (HP:0004944) | 2.06244373 |
109 | Hypergammaglobulinemia (HP:0010702) | 2.05734620 |
110 | Verrucae (HP:0200043) | 2.04805199 |
111 | Papilloma (HP:0012740) | 2.04805199 |
112 | Sepsis (HP:0100806) | 2.04427187 |
113 | Deep philtrum (HP:0002002) | 2.02225591 |
114 | Broad ribs (HP:0000885) | 2.01708457 |
115 | Bronchitis (HP:0012387) | 1.99085205 |
116 | Glomerulopathy (HP:0100820) | 1.98747278 |
117 | Thyroiditis (HP:0100646) | 1.98690709 |
118 | Interstitial pulmonary disease (HP:0006530) | 1.96051329 |
119 | Skin ulcer (HP:0200042) | 1.94382808 |
120 | Acne (HP:0001061) | 1.94281102 |
121 | Skin rash (HP:0000988) | 1.93572716 |
122 | Lymphopenia (HP:0001888) | 1.92752277 |
123 | Alveolar cell carcinoma (HP:0006519) | 1.92560237 |
124 | Abnormality of the prostate (HP:0008775) | 1.91556931 |
125 | Keratitis (HP:0000491) | 1.91309954 |
126 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90642525 |
127 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90642525 |
128 | Amaurosis fugax (HP:0100576) | 1.90000020 |
129 | * Lymphoma (HP:0002665) | 1.89349426 |
130 | Papilledema (HP:0001085) | 1.87875818 |
131 | Mucopolysacchariduria (HP:0008155) | 1.87851775 |
132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87851775 |
133 | Abnormality of the pericardium (HP:0001697) | 1.87401015 |
134 | IgG deficiency (HP:0004315) | 1.86422089 |
135 | Polyneuropathy (HP:0001271) | 1.85108573 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 7.79717651 |
2 | GRK7 | 5.38903528 |
3 | JAK1 | 4.61983985 |
4 | MAP4K1 | 3.45459899 |
5 | ADRBK2 | 3.31803183 |
6 | RIPK4 | 3.31396617 |
7 | ITK | 3.28514986 |
8 | STK10 | 2.46724718 |
9 | JAK3 | 2.28421158 |
10 | MAP3K10 | 2.24590656 |
11 | EPHB1 | 2.09419100 |
12 | PRPF4B | 1.89289773 |
13 | MST4 | 1.85627862 |
14 | TYK2 | 1.83673676 |
15 | FES | 1.83220728 |
16 | CSK | 1.80919103 |
17 | ZAP70 | 1.76892902 |
18 | MAP2K3 | 1.72512876 |
19 | LCK | 1.66381384 |
20 | RIPK1 | 1.63633369 |
21 | GRK6 | 1.59839206 |
22 | TGFBR2 | 1.56318206 |
23 | TTN | 1.56177688 |
24 | TRIB3 | 1.53202351 |
25 | FGFR4 | 1.51097711 |
26 | MAP3K11 | 1.49419971 |
27 | PRKCH | 1.40354606 |
28 | EPHA3 | 1.24469332 |
29 | LRRK2 | 1.20256521 |
30 | KDR | 1.19848717 |
31 | FGFR3 | 1.17115709 |
32 | PIM1 | 1.16045682 |
33 | TAOK3 | 1.13888435 |
34 | PRKCQ | 1.13525905 |
35 | BTK | 1.09304892 |
36 | MAP3K3 | 1.08491706 |
37 | SIK2 | 0.98590185 |
38 | TNK2 | 0.97685787 |
39 | CDK4 | 0.97347005 |
40 | SYK | 0.96309675 |
41 | BMPR2 | 0.95392420 |
42 | HCK | 0.94471374 |
43 | KIT | 0.93312102 |
44 | BLK | 0.92955710 |
45 | MAP3K14 | 0.90114381 |
46 | IKBKE | 0.88754510 |
47 | NLK | 0.86796328 |
48 | CAMKK2 | 0.86033978 |
49 | TBK1 | 0.83533844 |
50 | SIK3 | 0.80243820 |
51 | MARK3 | 0.79293157 |
52 | CLK1 | 0.78895828 |
53 | CDK12 | 0.78539885 |
54 | DMPK | 0.77918509 |
55 | ALK | 0.76512289 |
56 | IRAK3 | 0.75507436 |
57 | IGF1R | 0.75384061 |
58 | TEC | 0.74700462 |
59 | JAK2 | 0.70860540 |
60 | TLK1 | 0.70035970 |
61 | MAP3K1 | 0.67715700 |
62 | STK24 | 0.65792300 |
63 | PKN2 | 0.64670759 |
64 | LYN | 0.61596735 |
65 | INSR | 0.61100583 |
66 | TYRO3 | 0.59772253 |
67 | MATK | 0.59706704 |
68 | CAMKK1 | 0.59523757 |
69 | MOS | 0.59311226 |
70 | BMX | 0.58408711 |
71 | RPS6KA4 | 0.57707591 |
72 | GSK3A | 0.56950140 |
73 | EEF2K | 0.55994872 |
74 | PRKD2 | 0.53206896 |
75 | PDGFRB | 0.50846185 |
76 | ERN1 | 0.49376590 |
77 | HIPK2 | 0.48547109 |
78 | MAPK12 | 0.45945523 |
79 | IRAK4 | 0.44541166 |
80 | PTK6 | 0.44197908 |
81 | FYN | 0.43387453 |
82 | KSR2 | 0.43205432 |
83 | PTK2 | 0.42904945 |
84 | GRK5 | 0.41549304 |
85 | TAOK2 | 0.41063067 |
86 | MAP3K7 | 0.40389463 |
87 | MAP2K6 | 0.40081299 |
88 | MAPKAPK2 | 0.39328572 |
89 | PDK1 | 0.38544989 |
90 | YES1 | 0.37701138 |
91 | STK11 | 0.36017602 |
92 | STK38 | 0.35034314 |
93 | MARK2 | 0.35014606 |
94 | TESK2 | 0.34827562 |
95 | PDPK1 | 0.34607454 |
96 | MAPK7 | 0.34106812 |
97 | PRKG2 | 0.33469692 |
98 | FGR | 0.33191736 |
99 | IRAK1 | 0.32640057 |
100 | BCKDK | 0.31604189 |
101 | NUAK1 | 0.31467038 |
102 | MUSK | 0.31322060 |
103 | TRPM7 | 0.30924927 |
104 | FGFR1 | 0.30182868 |
105 | PASK | 0.30020655 |
106 | MELK | 0.28895949 |
107 | MAP3K2 | 0.28450862 |
108 | MAPK11 | 0.27597024 |
109 | PRKCD | 0.27440042 |
110 | CSF1R | 0.27231545 |
111 | PIK3CA | 0.25737520 |
112 | MAP3K5 | 0.25547567 |
113 | MAP3K8 | 0.25157376 |
114 | BRD4 | 0.25025227 |
115 | ABL1 | 0.24712764 |
116 | MAP3K13 | 0.24572823 |
117 | SRC | 0.24056429 |
118 | MAP3K6 | 0.23496942 |
119 | TESK1 | 0.22774645 |
120 | CDC42BPA | 0.22712028 |
121 | PAK4 | 0.22649920 |
122 | RET | 0.22528135 |
123 | IKBKB | 0.22482180 |
124 | ROCK2 | 0.22200298 |
125 | CAMK1G | 0.22014558 |
126 | MAPK4 | 0.21808517 |
127 | ILK | 0.21053990 |
128 | CDK6 | 0.19231890 |
129 | SGK3 | 0.19207799 |
130 | TAOK1 | 0.18520964 |
131 | RPS6KA1 | 0.18425529 |
132 | PIK3CG | 0.16808250 |
133 | MYLK | 0.16637742 |
134 | PTK2B | 0.15826940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 7.65820216 |
2 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 5.43169447 |
3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.64692165 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.56044805 |
5 | * Allograft rejection_Homo sapiens_hsa05330 | 3.49500544 |
6 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.50212021 |
7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.35741477 |
8 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34350400 |
9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.21458581 |
10 | Measles_Homo sapiens_hsa05162 | 2.10274750 |
11 | Malaria_Homo sapiens_hsa05144 | 1.89625044 |
12 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.83885672 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80413509 |
14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73055645 |
15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62250156 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61224732 |
17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60092751 |
18 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52309996 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32778844 |
20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30638709 |
21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21256286 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.19148553 |
23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.18873477 |
24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18676765 |
25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15537367 |
26 | * Apoptosis_Homo sapiens_hsa04210 | 1.15479314 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.15316347 |
28 | Shigellosis_Homo sapiens_hsa05131 | 1.12321326 |
29 | Asthma_Homo sapiens_hsa05310 | 1.08539737 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05483873 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05039375 |
32 | Platelet activation_Homo sapiens_hsa04611 | 1.03612846 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.02461855 |
34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97400192 |
35 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97119130 |
36 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96847205 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 0.90949968 |
38 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88304379 |
39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87765704 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85909065 |
41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84915567 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 0.84597451 |
43 | Endocytosis_Homo sapiens_hsa04144 | 0.83768736 |
44 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83636505 |
45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82992611 |
46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82838877 |
47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82653821 |
48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82315306 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 0.81121170 |
50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78013918 |
51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76280018 |
52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74629607 |
53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74603884 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.74521625 |
55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73233843 |
56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69010203 |
57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67423377 |
58 | Influenza A_Homo sapiens_hsa05164 | 0.64079382 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62686633 |
60 | Focal adhesion_Homo sapiens_hsa04510 | 0.61166174 |
61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59733175 |
62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.59389985 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.57731621 |
64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56991084 |
65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53598923 |
66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52234772 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51176905 |
68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50939242 |
69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49883409 |
70 | Legionellosis_Homo sapiens_hsa05134 | 0.48844877 |
71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48034770 |
72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47787505 |
73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46854018 |
74 | Hepatitis C_Homo sapiens_hsa05160 | 0.44217560 |
75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43594906 |
76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42871744 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42090366 |
78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41876269 |
79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41558895 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41325676 |
81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40854268 |
82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40074529 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38150143 |
84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38078741 |
85 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37568122 |
86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35818566 |
87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33752107 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32496896 |
89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31077092 |
90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30738102 |
91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29680340 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28910704 |
93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28793811 |
94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27261599 |
95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26275691 |
96 | Adherens junction_Homo sapiens_hsa04520 | 0.25598484 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25190872 |
98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25175519 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.24553268 |
100 | Insulin resistance_Homo sapiens_hsa04931 | 0.24501707 |
101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24170150 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22699543 |
103 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.21511739 |
104 | Lysosome_Homo sapiens_hsa04142 | 0.20824817 |
105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.20040093 |
106 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19869516 |
107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19573409 |
108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18581033 |
109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.17955910 |
110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17646545 |
111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17251229 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17149267 |
113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15226030 |
114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14836143 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.14449185 |
116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.14071308 |
117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14009927 |
118 | ABC transporters_Homo sapiens_hsa02010 | 0.13958360 |
119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13560831 |
120 | Phagosome_Homo sapiens_hsa04145 | 0.13208602 |
121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12677603 |
122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11909147 |
123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.11867116 |